Stock TCRT ALAUNOS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Alaunos Therapeutics, Inc.

Equities

TCRT

US98973P2002

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.33 USD +0.76% Intraday chart for Alaunos Therapeutics, Inc. +22.02% +25.41%
Apr. 01 Alaunos Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 05 North American Morning Briefing : S&P 500 Futures -2- DJ

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ziopharm: Q3 Earnings Snapshot
AQ
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
AQ
Ziopharm: Q2 Earnings Snapshot
AQ
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
AQ
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies
AQ
ALAUNOS THERAPEUTICS, INC. : Material Modification to Rights of Security Holders, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting
AQ
Ziopharm: Q1 Earnings Snapshot
AQ
ALAUNOS THERAPEUTICS, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
Alaunos Therapeutics Reports First Quarter 2023 Financial Results
AQ
Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023
AQ
Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
AQ
ALAUNOS THERAPEUTICS, INC. : Entry into a Material Definitive Agreement (form 8-K)
AQ
ALAUNOS THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
AQ
Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April
AQ
Ziopharm: Q4 Earnings Snapshot
AQ
ALAUNOS THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)
AQ
Alaunos Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results
AQ
Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TCRT Stock
  4. News Alaunos Therapeutics, Inc.
  5. Press Releases